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› -hydroxybutyrate and acetoacetate as well as lactate and pyruvate
are intermediary metabolites normally present in blood. The › -
hydroxybutyrate/acetoacetate ratio is an expression of the mitochon-
drial oxido-reduction state. This ketone body ratio can provide a
clue to diagnosis and metabolic status in congenital errors of the
electron transport chain and pyruvate metabolism. The standardi-
zation of these analytical procedures improves the interpretation
of the results helping in the di¤cult diagnosis of mitochondrial
diseases in children. This study describes an adaptation to a
Dimension R £ L (Dade Behring, Newark, Delaware, USA)
automatic analyser for a method to measure blood ketone bodies
(› -hydroxybutyrate and acetoacetate). The method allows the
metabolites to be measured directly in nondeproteinized plasma
(£uoride/ethylenediaminetetraacetic acid). This adaptation sim-
pli¢es the analytical procedure and limits the turnaround time to 20
minutes. With a sample volume of 200ml metabolite concentrations
ranging from 12 to 1300 mmolL¡1 of › -hydroxybutyrate and from
10 to 450mmolL¡1 of acetoacetate may be measured with a
reliable analytical response.
Introduction
Ketone bodies are produced in the liver, mainly from the
oxidation of fatty acids, and are exported to peripheral
tissues for use as an energy source. The term ` ketone
bodies’ refers to three molecules, acetoacetate, b-hydro-
xybutyrate and acetone. Acetoacetate and b-hydroxy-
butyrate transport energy from the liver to other tissues
and acetone is generated by spontaneous decarboxylation
of acetoacetate [1]. The presence of ketosis may be
normal or pathologic. Normally ketosis implies that the
lipid energy metabolism has been activated and the
pathway of lipid degradation is intact. Ketosis is a
physiological ® nding in many circumstances such as
during fasting, after prolonged exercise or after a high
fat diet. However, as a general rule, hyperketosis, at a
level that produces metabolic acidosis is not physiologic.
Pathological causes of ketosis include diabetes, child-
hood hypoglycaemia, corticosteroid or growth hormone
de® ciency, intoxication with alcohol or salicylates and
several inborn errors of metabolism, as well as multiple
organ failure.
Ketosis with an abnormal elevation of the b-hydroxy-
butyrate/acetoacetate ratio implies a disorder of the
intramitochondrial redox state [2]. These situations
may be present in inborn metabolic diseases that aå ect
fuel homeostasis such as disorders of the Krebs cycle,
disorders of the mitochondrial respiratory chain, ketogen-
esis or ketolysis [3± 5]. In these cases the evaluation of
the lactate/pyruvate ratio together with the b-hydroxy-
butyrate/acetoacetate ratio are the tools of ® rst choice
in determining the cytoplasmatic and mitochondrial
oxido-reduction state respectively of the individual [4].
The ® rst application of these assays is in the screening for
the diagnosis of mitochondrial cytopathies [6]. The
determination of these ratios in the basal state or follow-
ing an eå ort test [4, 7], may diagnose or discount a
mitochondrial cytopathy. If these test results are normal,
a biopsy may be avoided.
Spectrophotometric determinations of circulating aceto-
acetate and hydroxybutyrate have been reported [8, 9]
and adapted to several automatic analysers [10± 14].
The quanti® cation of ketone bodies presents technical
(manual preparation of reagents, complexity of the pre-
analytical phase, long analytical response times) and
diagnostic (intraindividual variations, wide reference
ranges, need for support from other biochemical param-
eters for result interpretation) interpretation diæ culties
[15].
With the aim of standardizing the analytical procedures
and facilitating their application as routine techniques we
have adapted the methods proposed by Vassault et al.
[16] to measure ketone bodies on a Dimension R £ L
(Dade Behring, Newark, Delaware, USA) automatic
analyser. The study was performed on two types of
sample: deproteinized plasma with perchloric acid and
afterwards alkalinized, and plasma obtained directly
with ¯ uoride/ethylenediaminetetraacetic acid (EDTA).
Material and methods
Principle of the method
The two assays are based on end-point reactions cata-
lysed by b-hydroxybutyrate dehydrogenase at 378C and
diå erent pH conditions. The generation or consumption
of reduced nicotinamide ademine dinucleotide (NADH)
is measured by changes in absorbance at 340nm:
b-hydroxybutyrate ‡ NAD¡ Á ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ !
b¡hydroxybutyrate
dehydrogenase
acetoacetate ‡ NADH¡ ‡ H‡
To complete the b-hydroxybutyrate reaction a pH of
9.5 is necessary while the acetoacetate assay requires a
pH of 7.
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69Reagents and work solutions
b-Hydroxybutyrate
. Reagent 1: 168mmolL
¡1: nicotinamide adenine
dinucleotide (NAD) (Roche catalogue 127841) in
distilled water. Stable for 6 months when frozen at
¡20 8C in aliquots.
. Reagent 2: 0.1molL
¡1 tris buå er (tris(hydroxy-
methyl)-aminomethane, Merck catatalogue 8382)
adjusted to pH 9.5 with HCl.
. Reagent 3: b-hydroxybutyrate dehydrogenase
(EC1.1.1.30) (HBDH Roche catalogue 127841; spe-
ci® c activity: 3Umg
¡1 (258C). Stable at 48C.
. b-hydroxybutyrate standards to calibrate the
method: d,l b-hydroxybutyric acid, sodium salt
(Sigma H6501). Prepare 0, 50, 250, 500 and
1250 mmolL
¡1 solutions in distilled water. Stable
for 6 months when frozen at ¡208C in aliquots.
Acetoacetate
. Reagent 1: 4mmolL¡1 NADH (Roche catalogue
128023) in distilled water. Stable for 6 months
when frozen at ¡208C in aliquots.
. Reagent 2: 0.1molL
¡1 tris buå er (tris(hydroxy-
methyl)-aminomethane, Merck catalogue 8382)
adjusted to pH 7.
. Reagent 3: b-hydroxybutyrate dehydrogenase
(EC1.1.1.30) (Roche catalogue 127841); speci® c
activity 3Umg¡1 (258C). Stable at 48C.
. Acetoacetate standards to calibrate the method:
acetoacetic acid salt (Sigma, catalogue A-8509).
Prepare 0, 50, 100, 200 and 400mmol L¡1 solutions
in distilled water. Stable for 4 weeks when frozen at
¡20 8C in aliquots.
Reagents for specimen preparation
For deproteinized plasma samples: 1molL¡1 perchloric
acid (Merck catalogue 519) and 0.7molL¡1 tripotassium
phosphate (Merck catalogue 5102).
For plasma samples: ¯ uoride/EDTA (Roche catalogue
243710).
Automated assay
The settings used on the Dimension R £ L analyser are
listed in tables 1 and 2.
Calibration method
Calibration was with b-hydroxybutyrate and aceto-
acetate standards described in Reagents and work solutions
above. b-Hydroxybutyrate was calibrated following a
logarithmic reaction and acetoacetate a linear reaction.
Subjects
Reference values were calculated from 60 samples ob-
tained from apparently normal children, and were sent to
our laboratory for analytical control before minor surgi-
cal interventions were carried out on the patients. Blood
samples were obtained after 12 hours of fasting. The age
range of the children was 1 month to 14 years. The
specimens were assayed the same day as the blood
samples were obtained.
20 of these values were used to study the comparison
between plasma and deproteinized plasma samples. 20
apparently normal subjects (age range 20± 60 years),
20 patients with diabetic ketosis and another 20
patients with metabolic disorders were also included in
the study.
Specimens
The blood specimens (1ml) were added immediately to
tubes containing 1ml cold 1molL¡1 perchloric acid. The
samples were mixed and centrifuged (3000£g for 10
minutes). The deproteinized supernatants were stored at
¡208C until analysis. The supernatants were adjusted to
Table 1. Settings for › -hydroxybutyrate determination by the dimension R £ L analyser.
Reagent and sample delivery
First reagent (R1) Second reagent (R2) Third reagent (R3)
Setting Sample (S1) (NAD 168 mM) (Tris 0.1M pH 9) (HBDH 15 Uml
¡1)
Delivery time (s) 0.0 760.0 65.3 125.3
Volume delivery (ml) 60 20.0 245.0 12.0
Chase delivery (ml) 0.0 0.0 20.0 20.0
Mix None None Moderate Moderate




First ® lter 340 nm
Secondary ® lter 700 nm




Dilution C ˆ A £ …¡0:915† ‡ B £ …1:0†
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70pH 7 with 0.7molL¡1 tripotassium phosphate, stored for
15 minutes at 48C and then centrifuged. The alkalinized
supernatants were used to measure the ketone bodies.
To obtain plasma samples 1ml blood was added to tubes
containing 1 drop of ¯ uoride/EDTA and then mixed.
The supernatants obtained after centrifuging at 3000£g
for 10 minutes were stored at ¡20 8C and used to
measure the ketone bodies.
Quality control
b-Hydroxbutyrate and acetoacetate standards, at two
levels, were always assayed with patient samples ® rst at
one level and at the end of the batch at the other level.
The assay was considered to be correct if the standard
values were within §10% of the assigned value.
Evaluation of the method
The analytical interval and the detection limit of the
methods were evaluated following the directions of the
Socite¨ Franmaise de Biologie Clinique [17]. To calculate
the analytical interval the following standard aqueous
solutions were used: 2500, 2000, 1250, 500, 250, 100, 25,
0.1mmolL¡1 of d,l-b-hydroxybutyric acid, sodium salt,
and 600, 500, 250, 100, 50, 25, 10, 5, 0.1mmolL¡1
acetoacetic acid salt. The detection limit (Ld) was
established following the processing of 10 specimens of
distilled water. With the mean (md) and the standard
deviation (SD) the detection limit for an ¬ and › risk of
5% (K ˆ 5:185) was calculated (Ld ˆ md ‡ K SD) [17].
The recommendations of the European Committee for
Clinical Laboratory Standards (ECCLS) were followed
for the study of the imprecision and inaccuracy of the
method [18]. 50,100 and 200mmol L¡1 hydroxybutyrate
and acetoacetate standard aqueous solutions were used.
To determine the analytical recovery of the methods,
increasing quantities of b-hydroxybutyrate or acetoace-
tate were added to diå erent aliquots of the pool of sera.
430, 700 and 1000mmolL¡1 hydroxybutyrate and 100,
200 and 400molL¡1 acetoacetate were the standard
aqueous solutions used. The dilution eå ect was corrected
by adding the same volume of saline solution to unaltered
samples.
The reference values of the methods were obtained
following the recommendations of the Panel of Experts
of the International Federation of Clinical Chemistry on
reference values [19].
Sample evaluation : deproteinized plasma or not
b-Hydroxybutyrate and acetoacetate were assayed in 80
patients in replicate using as samples plasma obtained
directly with ¯ uoride/EDTA and deproteinized plasma
with perchloric acid. Comparison studies were performed
among the results from the two diå erent samples.
Statistical methods
The mean, standard deviation and coeæ cient of vari-
ation for studying the accuracy, imprecision and detec-
tion limit were obtained. The Student’ s t test was applied
to compare the types of sample. Regression analyses were
applied to obtain the analytical interval. The Mann±
Whitney test was applied to establish the statistical
diå erences between groups. To calculate the reference
values of the method, the 2.5, 50 and 97.5 percentiles
were used.
Results
Detection limit and analytical interval of methods
The detection limit established was 12mmolL¡1 for b-
hydroxybutyrate and 6mmol L¡1 for acetoacetate. The
analytical interval of the methods ranged from 12 to
1300 mmol L¡1 for b-hydroxybutyrate and from 10 to
450 mmol L¡1 for acetoacetate. Figure 1 shows the slope
Table 2. Settings for acetoacetate determination by the Dimension R £ L analyser.
Reagent and sample delivery
First reagent (R1) Second reagent (R2) Third reagent (R3)
Setting Sample (S1) (NAH 4mM) (Tris 0.1M pH 7) (HBDH 15 Uml
¡1)
Delivery time (s) 0.0 760.0 65.3 125.3
Volume delivery (ml) 95 16.0 95.0 5.0
Chase delivery (ml) 0.0 0.0 20.0 20.0
Mix None None Moderate Moderate




First ® lter 340 nm
Secondary ® lter 700 nm




Dilution C ˆ A £ …¡0:900† ‡ B £ …1:0†
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71of linear regression of the least squares
(y ˆ 1:023 £ ¡2:349; r ˆ 0:989) of the reference hydro-
xybutyrate standards processed in triplicate over 3 con-
secutive days, and the values found. The linear regression
for the acetoacetate standard was y ˆ 1:020 £ ¡3:01 ;
r ˆ 0:976) (® gure 2).
Imprecision and inaccuracy. Table 3 demonstrates the
within-run and between-run coeæ cients of variation of
the aqueous standards of b-hydroxybutyrate and acet-
oacetate at three concentration levels, as well as those of
the serum specimen. The percentages of inaccuracy with
respect to the theoretical value (table 4) did not exceed
10%.
Analytical recovery study. Analytical recovery ranged from
97 to 104% for hydroxybutyrate and 98 to 103% for
acetoacetate (table 5).
Reference values. Table 6 contains the reference values for
the studied population which was divided into two
groups (1 month to 7 years and 7 to 14 years). Statistical
diå erences between the two groups were found for the
b-hydroxybutyrate (p ˆ 0:032) and acetoacetate
(p ˆ 0:041) results, but no diå erences were found for
the b-hydroxybutyrate/acetoacetate ratio (p ˆ 0:200).
Comparison between plasma and deproteinized plasma samples.
No statistical diå erences were found for the concentra-
tions of b-hydroxybutyrate (t ˆ ¡0:287; p ˆ 0:775) and
acetoacetate (t ˆ ¡0:430, p ˆ 0:669) using deproteinized
plasma with perchloric and non-deproteinized plasma
(¯ uoride/EDTA) (table 7).
Discussion
The determination of levels of blood ketone bodies is
an infrequent type of analysis in clinical biochemistry
laboratories. There are several reasons for this. Firstly,
clinical interpretation of these results is diæ cult because
of intraindividual variations, thereby making it diæ cult
to establish reference values. Secondly, there are many
physiological situations in which ketosis may be pro-
duced, thus to achieve a correct diagnosis of hyperketosis,
other metabolites, such as glucose, lactate, pyruvate or
amino acids, should be measured simultaneously. There-
fore, use of blood ketone bodies is restricted to some
concrete and diæ cult diagnoses. An example is the
investigation of inborn errors of intermediary metab-
olism, especially aå ecting energetic homeostasis (defects
of the mitochondrial respiratory chain, b-oxidation,
ketogenesis and ketolysis). Since the incidence of these
diseases is low, few manufacturers have been motivated
to elaborate commercial kits for measuring these meta-
bolites and even less to implement them in an automatic
Figure 1. Analytical interval for › -hydroxybutyrate. (ö), Reference line y ˆ bx (b ˆ 1); (-----) regression line
(y ˆ 1:023x ¡ 2:349); (> ? -) mean and two standard deviations of each point. The mean values of the points found and their two
standard deviations coincide with the reference line from 12 to 1300mmolL¡1.
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72analyser. The manual practice of these assays does not
favour their use since the preparation of the reagents and
the assay itself are laborious, time-consuming, require
high reagent and sample volumes, and give elevated
imprecisions [8, 9].
Similar to several previous works [10± 14], we have
automated a spectrometric method [16] to measure
ketone bodies in a Dimension R £ L analyser, which
is available 24 hours a day in the laboratory. With
this adaptation we have improved notably the
analytical reliability of our results in addition to saving
time, and reagent and sample volume. This is an import-
ant point to take into account since most samples
are of paediatric origin. Moreover, complementary
analyses must be performed to achieve the diagnosis
Figure 2. Analytical interval for acetoacetate. (ö), Reference line y ˆ bx (b ˆ 1); (-----) regression line (y ˆ 1:020x ¡ 3:01);
(> ? -) mean and two standard deviations of each point. The mean values of the points found and their two standard deviations coincide with
the reference line from 10 to 450mmolL¡1.
Table 3. Imprecision of the methods.
b-Hydroxybutyrate
Concentration level N Within-run CV(%) Between-run (CV%)
Aqueous b-hydroxybutyrate solution (50mmolL
¡1) 20 6 9.5
Aqueous b-hydroxybutyrate solution (100mmolL
¡1) 20 5 9.1
Aqueous b-hydroxybutyrate solution (200mmolL
¡1) 20 4 7.3
Serum pool (170mmolL
¡1) 20 5.1 Ð
Deproteinized plasma pool (110 mmolL
¡1) 20 5.2 Ð
Acetoacetate
Concentration level N Within-run CV(%) Between-run (CV%)
Aqueous acetoacetate solution (50mmolL
¡1) 20 5 9.5
Aqueous acetoacetate solution (100mmolL
¡1) 20 4 9.1
Aqueous acetoacetate solution (200mmolL
¡1) 20 3 7.3
Serum pool (96mmolL
¡1) 20 4.5 Ð
Deproteinized plasma pool (141 mmolL
¡1) 20 4.9 Ð
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73Table 4. Inaccuracy of methods.
b-Hydroxybutyrate
Within-run Between-run




¡1) Inaccuracy (%) (mmolL
¡1) Inaccuracy (%)
50 20 53 6 47 76
100 20 101 1 105 5
200 20 198 71 186 77
Acetoacetate
Within-run Between-run




¡1) Inaccuracy (%) (mmolL
¡1) Inaccuracy (%)
50 20 48 74 53 6
100 20 98 72 92 78.0
200 20 195 72.5 215 7.5










200 430 630 655 104
200 700 900 873 97










80 100 180 176 98
80 200 280 288 103
80 400 480 475 99
Table 6. Reference values.
0± 7 years (n ˆ 30) 7± 14 years (n ˆ 30)
b-Hydroybutyrate (mmolL
¡1)
Range (p2:5;p97:5) 20± 700 20± 500
Mean value (p50) 60 40
Acetoacetate (mmolL
¡1)
Range (p2:5;p97:5) 10± 200 10± 140
Mean value (p50† 45 31
› -Hydroybutyrate/acetoacetate
Range (p2:5;p97:5) 0.04± 4.0 0.04± 3.5
Mean value (p50) 1.3 1.1
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analyser.
Another diæ culty, from the technical point of view, in
analysing ketone bodies derives from sample collection.
Acetoacetate is an unstable metabolite [16] thus it is
recommended that the blood be collected immediately
after its withdrawal in an acid medium to be depro-
teinized as well as the samples be maintained in ice until
processing. Other authors [13, 16], who usually deter-
mine lactate, pyruvate and ketone bodies in the same
sample, recommend the use of deproteinized plasma with
perchloric acid. We also perform our assays in this type
of sample. However, we have observed that the results
using plasma collected directly in ¯ uoride/EDTA are
similar to those obtained from deproteinized plasma
with perchloric acid. On the other hand, statistically
signi® cant diå erences were found (n ˆ 80, t ˆ 8:08,
p < 0:001) between using deproteinized plasma (y) and
non deproteinized plasma (¯ uoride/EDTA) (x) in the
quanti® cation of pyruvate (y ˆ 1:74x ‡ 4:62; r ˆ 0:599)
(data not included in the study). We did not observe
diå erences in the lactate values using these two types of
sample (n ˆ 80, t ˆ 0:118, p ˆ 0:779). Thus, if the four
metabolites are to be measured in the same sample it is
necessary to use deproteinized plasma in an acid medium
after extraction because the pyruvate values may be
incorrect. However, the ketone bodies may be evaluated
directly in a serum sample which has been withdrawn
with ¯ uoride/EDTA with the aim of measuring its lactate
for example. There are several advantages to working
directly with non-deproteinized plasma. The possible
dilution error (which falsi® es the absolute value of the
metabolites although not their ratios) is minimized.
Additionally, the analytical procedure is reduced by 30
minutes. The present adaptation, especially using non-
deproteinized plasma, simpli® es the anaytical procedure
and, although the preparation of reagents is somewhat
laborious, the fact that they may be stored frozen, allows
the assay to be performed with relative ease in emergency
situations.
We have established our reference values for a population
under the age of 14 years. Signi® cant diå erences were
found in two age groups for the two metabolites, but not
for their ratios. These results have been reported by
Artuch et al. [13]. Similar to other reports [13, 20], our
reference values present a wide range of values. Many
intraindividual variations may be due to the nutritional
state of the patient.
In summary, this adaptation facilitates the measurement
of sanguineous ketone bodies and provides a rapid and
reliable method with low sample consumption and which
may to be applied as a routine technique in an emer-
gency laboratory. The main application of this method is
to contribute to the diagnosis of mitochondrial diseases
both in the ® rst orientation as well as in subsequent
provocative tests [6, 7].
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